Cancer Immunotherapy intermediate
Checkpoint Inhibitor CD28
Reference for checkpoint inhibitor CD28 in peptide research.
By Encyclopeptide Editorial | 1 min read
checkpoint-inhibitor CD28 checkpoint inhibitor cancer-immunotherapy
Overview
checkpoint inhibitor CD28 is a peptide studied in cancer immunotherapy research.
Properties
| Property | Value |
|---|---|
| Parent | checkpoint-inhibitor |
| Variant | CD28 |
| Type | Checkpoint inhibitor |
| Category | Cancer Immunotherapy |
Significance
This checkpoint inhibitor has been investigated for its biological activity and therapeutic potential.
References
- Encyclopeptide Database. “checkpoint-inhibitor-CD28” monograph. encyclopeptide.com.
Chemical Identity
| Property | Value |
|---|---|
| Name | Checkpoint Inhibitor CD28 |
| Category | Cancer Immunotherapy |
Test Your Knowledge
Reinforce what you learned about Checkpoint Inhibitor CD28 with interactive quizzes on Wikipept.
Take a Quiz on Wikipept